Anticipating the future: The diagnosis of Alzheimer's disease in the predementia and prodromal phases;Anticipando el futuro: Diagnóstico de la enfermedad de Alzheimer en las fases predemencia y prodrómica

Revista de Neurologia

Volumn 51, Issue 8, 2010, Pages 449-450

  Berthier, Marcelo L ^a   Dávila, Guadalupe ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; EDITORIAL;

EID: 78649839408     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5108.2010543     Document Type: Editorial

References (12)

1. Franz CE, Barker JC, Kim K, Flores Y, Jenkins C, Kravitz RL, et al. When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease. Am J Geriatr Psychiatry 2010; 18: 576-85.
2. Molinuevo JL, Berthier ML, Rami L. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment. Arch Gerontol Geriatr 2009; Nov 28. [Epub ahead of print].
3. Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther 2009; 1: 7.
4. Valls-Pedret C, Molinuevo JL, Rami L. Diagnóstico precoz de la enfermedad de Alzheimer: fase prodrómica y preclínica. Rev Neurol 2010; 51: 471-80.
5. Kenfield MC, Arciniegas DB, Anderson CA, Howard KL, Filley CM. When cognitive evaluation does not disclose a neurologic disorder: experience of a university behavioral neurology clinic. Cogn Behav Neurol 2010; 23: 112-8.
6. Roberts JS, Karlawish JH, Uhlmann WR, Petersen RC, Green RC. Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurology 2010; 75: 425-31.
7. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-88.
8. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet 2007; 6: 734-46.
9. Opar A. Hope builds for earlier detection of Alzheimer's disease. New recommendations to change the diagnostic criteria for Alzheimer's disease and recent advances in biomarker development may allow earlier diagnosis of this disease, potentially providing key tools for drug development. Nat Rev Drug Discov 2010; 9: 579-81.
10. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007; 130: 2636-45. (Pubitemid 47511719)
11. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008; 71: 1227-34.
12. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008; 25: 268-78.